BARDA boosts the fight against antibiotic-resistant infections with $144M awards
In a first, BARDA has offered a $76.9 million award to fund a microbiome-based therapy’s last dash toward the FDA while promising $77 million for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
